EFFICACY AND SAFETY OF PENTAVALENT HUMAN-BOVINE REASSORTANT ROTAVIRUS VACCINE WHEN ADMINISTERED WITH GREATER THAN 10 WEEKS BETWEEN DOSES

被引：13
|
作者：
Goveia, Michelle G. [1 ]
Suprun, Leora [1 ]
Itzler, Robbin F. [1 ]
McFetridge, Richard [1 ]
Dallas, Michael J. [1 ]
Kuter, Barbara J. [1 ]
机构：
[1] Merck & Co Inc, West Point, PA 19486 USA
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2010年 / 29卷 / 03期
关键词：
rotavirus; RotaTeq; pentavalent rotavirus vaccine; dosing window;
D O I：
10.1097/INF.0b013e3181be6257
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The pentavalent human-bovine reassortant rotavirus vaccine is indicated as a 3-dose series with first dose administered orally at 6 to 12 weeks with subsequent doses at 4 to 10 week intervals. In pre-licensure phase III trials, the majority followed this schedule, but there were 2956 instances where infants received a dose of pentavalent human-bovine reassortant rotavirus vaccine/placebo >10 weeks after the previous dose. Among this subset, the efficacy against any severity of disease, the reduction in utilization of healthcare resources and the safety profile after vaccination were comparable with overall results.
引用
收藏
页码：263 / 265
页数：3
相关论文
共 50 条
  • [21] Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5)
    Itzler, Robbin
    Koch, Gary
    Matson, David O.
    Gothefors, Leif
    Van Damme, Pierre
    DiNubile, Mark J.
    Heaton, Penny M.
    BMC PEDIATRICS, 2010, 10
  • [22] Concomitant use of an oral live pentavalent human-bovine reassortant rotavirus vaccine with licensed parenteral pediatric vaccines in the United States
    Rodriguez, Zoe M.
    Goveia, Michelle G.
    Stek, Jon E.
    Dallas, Michael J.
    Boslego, John W.
    DiNubile, Mark J.
    Heaton, Penny M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (03) : 221 - 227
  • [23] Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants
    Vesikari, Timo
    Clark, H. Fred
    Offit, Paul A.
    Dallas, Michael J.
    DiStefano, Daniel J.
    Goveia, Michelle G.
    Ward, Richard L.
    Schodel, Florian
    Karvonen, Aino
    Drummond, James E.
    DiNubile, Mark J.
    Heaton, Penny M.
    VACCINE, 2006, 24 (22) : 4821 - 4829
  • [24] Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants (vol 144, pg 184, 2004)
    Clark, HF
    JOURNAL OF PEDIATRICS, 2004, 144 (04): : 558 - 558
  • [25] VACCINE-DERIVED HUMAN-BOVINE DOUBLE REASSORTANT ROTAVIRUS IN INFANTS WITH ACUTE GASTROENTERITIS
    Hemming, Maria
    Vesikari, Timo
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (09) : 992 - 994
  • [26] Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial
    Mo, Zhaojun
    Mo, Yi
    Li, Mingqiang
    Tao, Junhui
    Yang, Xu
    Kong, Jilian
    Wei, Dingkai
    Fu, Botao
    Liao, Xueyan
    Chu, Jianli
    Qiu, Yuanzheng
    Hille, Darcy A.
    Nelson, Micki
    Kaplan, Susan S.
    VACCINE, 2017, 35 (43) : 5897 - 5904
  • [27] Literature review to identify evidence of secondary transmission of pentavalent human-bovine reassortant rotavirus vaccine (RV5) strains to unvaccinated subjects
    Li, Yuanqiu
    Sun, Xiaojin
    Fu, Yaqun
    You, Xuedan
    Hartwig, Susanne
    VACCINE, 2024, 42 (07) : 1461 - 1468
  • [28] Efficacy of the pentavalent rotavirus vaccine in subjects after 1 or 2 doses in the rotavirus efficacy and safety trial
    Bernstein, David
    PEDIATRICS, 2008, 121 (01) : 223 - 223
  • [29] A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants
    Kulkarni, Prasad S.
    Desai, Sajjad
    Tewari, Tushar
    Kawade, Anand
    Goyal, Nidhi
    Garg, Bishan Swarup
    Kumar, Dinesh
    Kanungo, Suman
    Kamat, Veena
    Kang, Gagandeep
    Bavdekar, Ashish
    Babji, Sudhir
    Juvekar, Sanjay
    Manna, Byomkesh
    Dutta, Shanta
    Angurana, Rama
    Dewan, Deepika
    Dharmadhikari, Abhijeet
    Zade, Jagdish K.
    Dhere, Rajeev M.
    Fix, Alan
    Power, Maureen
    Uprety, Vidyasagar
    Parulekar, Varsha
    Cho, Iksung
    Chandola, Temsunaro R.
    Kedia, Vikash K.
    Raut, Abhishek
    Flores, Jorge
    VACCINE, 2017, 35 (45) : 6228 - 6237
  • [30] Rotavirus immunoglobulin A responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccine
    Ward, RL
    Bernstein, DI
    Smith, VE
    Sander, DS
    Shaw, A
    Eiden, JJ
    Heaton, P
    Offit, PA
    Clark, HF
    JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (12): : 2290 - 2293
12345